Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Ville Platte › NPI 1407947336
Hospital

Clhg-Ville Platte LLC

Clhg-Ville Platte LLC was paid $5.76M by Medicaid between Jan 2018 and Nov 2024, across 135 billing codes. Its largest line is 99284, emergency room visit (serious) — 36% of everything it billed.

33Billing provider infoCLHG-VILLE PLATTE LLC
VILLE PLATTE, LA 70586
33aNPI1407947336assigned 09/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.76M
24GClaims205,736
24DCodes billed135
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#46 of 96
Median peer was paid$5.17M
This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201852,728$1.28M
201954,712$1.27M
202022,539$637K
202112,817$512K
202223,766$823K
202323,105$729K
2024incomplete16,069$507K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 36% 19,348 16,908 $2.09M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 30% 21,602 19,455 $1.74M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.9% 3,107 2,682 $511K
80053 Comprehensive metabolic panel 2.4% 21,914 17,851 $135K
G0378 Hospital observation service, per hour 2.0% 795 529 $112K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 2,072 1,954 $112K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.6% 3,253 2,851 $95K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 20,816 16,732 $90K
71045 Radiologic examination, chest; single view 1.4% 4,184 3,689 $82K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 2,682 1,474 $68K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 3,696 3,206 $63K
71046 Radiologic examination, chest; 2 views <1% 2,273 1,993 $53K
123 more codes
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,218 $50K
87276 <1% 3,786 $46K
36415 Collection of venous blood by venipuncture <1% 23,336 $38K
87275 <1% 3,793 $36K
58662 <1% 303 $36K
70450 Computed tomography, head or brain; without contrast material <1% 330 $35K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 86 $31K
87430 <1% 2,264 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,851 $26K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 84 $24K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 116 $22K
81001 <1% 11,488 $22K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,151 $16K
87081 <1% 1,902 $10K
83880 <1% 498 $10K
84484 <1% 1,489 $10K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 43 $10K
81025 <1% 1,538 $9K
84702 <1% 1,351 $7K
80050 General health panel <1% 183 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 22 $6K
83735 <1% 1,672 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 868 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 944 $5K
80061 Lipid panel <1% 504 $5K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 81 $5K
82550 <1% 1,160 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 376 $4K
00840 <1% 70 $4K
84443 Thyroid stimulating hormone (TSH) <1% 362 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 108 $4K
83690 <1% 832 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 214 $3K
87420 <1% 237 $3K
83655 <1% 271 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 37 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 194 $3K
93017 <1% 25 $2K
85730 <1% 1,225 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 26 $2K
96361 Intravenous infusion, hydration; each additional hour <1% 231 $2K
86850 <1% 1,512 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 313 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 465 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 74 $2K
85610 <1% 1,409 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 26 $2K
74019 <1% 97 $2K
82553 <1% 341 $2K
81003 <1% 1,326 $2K
86803 <1% 236 $2K
85027 <1% 290 $2K
87280 <1% 128 $2K
74018 <1% 72 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 444 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 190 $2K
86762 <1% 108 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 127 $1K
86901 <1% 1,566 $1K
86900 <1% 1,532 $1K
74021 <1% 61 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,397 $1K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 1,572 $962.25
86706 <1% 92 $949.44
87340 <1% 95 $907.33
J2704 Injection, propofol, 10 mg <1% 2,402 $832.21
J7120 Ringers lactate infusion, up to 1000 cc <1% 567 $753.84
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,335 $693.55
84146 <1% 33 $692.15
85007 <1% 289 $660.10
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 30 $641.16
80048 Basic metabolic panel (calcium, ionized) <1% 316 $620.60
85379 <1% 118 $596.93
93970 <1% 12 $430.54
84100 <1% 498 $427.57
86592 <1% 394 $417.87
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,899 $397.25
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 785 $393.22
84403 <1% 12 $367.02
82627 <1% 12 $316.26
83001 <1% 13 $287.70
83002 <1% 13 $286.66
84144 <1% 12 $273.58
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 13 $269.10
87040 <1% 51 $239.82
J3490 Unclassified drugs <1% 196 $234.14
82150 <1% 30 $199.58
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 402 $190.89
84439 <1% 32 $183.47
86703 <1% 16 $179.70
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 15 $164.32
J0780 Injection, prochlorperazine, up to 10 mg <1% 14 $161.55
36416 <1% 120 $150.56
85018 <1% 73 $147.46
85014 <1% 73 $147.46
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 100 $140.29
J2800 Injection, methocarbamol, up to 10 ml <1% 18 $137.79
87070 <1% 15 $129.57
87045 <1% 12 $127.60
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 52 $123.02
C1780 Lens, intraocular (new technology) <1% 70 $113.09
82043 <1% 18 $81.98
83605 <1% 14 $81.58
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 13 $75.08
84703 <1% 48 $74.75
82570 <1% 18 $73.44
85652 <1% 44 $70.49
82962 <1% 38 $65.33
J2550 Injection, promethazine hcl, up to 50 mg <1% 268 $63.56
82009 <1% 18 $40.83
85384 <1% 34 $38.98
C9399 Unclassified drugs or biologicals <1% 22 $17.26
86593 <1% 17 $14.72
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 13 $3.36
96127 0% 922 $0.00
A9270 Non-covered item or service 0% 423 $0.00
30140 0% 19 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 36 $0.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 0% 14 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 21 $0.00
0001A 0% 63 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 87 $0.00
0002A 0% 60 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGREEN, CALVIN (AUTHORIZED OFFICIAL/OFFICER)